Schedule 13D ownership disclosure

Furiex Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 36106P101

Event date: 2014-07-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-14-263381
Form type
SC 13D/A
Filer
Forest Laboratories, LLC
CIK
CIK 38074
Filed
Jul 09, 2014
Reporting period
Jul 02, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub